Medical Director Update

Medical Director Update

Latest study from the National Institute of Mental Health

By Mark Murphy, MD

As a board-certified anesthesiologist for 25 years, I have had extensive experience with Ketamine in the operative setting. Not only is it incredibly safe, it also has unique characteristics not found in other anesthetics. In more recent years I have seen this drug evolve into an amazing therapeutic option for treating chronic depression. However, one may always question whether anecdotal experience trumps the gold standard of the scientific method.

Therefore, as medical director here at Ketamine Wellness Centers, I think it’s important that patients and family members be updated with ongoing research regarding this drug and it’s assimilation into mainstream therapy, whether involving the treatment of depression or chronic pain. Recently, the National Institute of Mental Health released a study identifying the metabolic component of Ketamine that acts at a specific receptor site in the central nervous system responsible for alleviating symptoms of depression.

Ketamine was always thought to work by blocking NMDA (N-methyl-D-aspartate) glutamate receptors in the CNS. But now it appears the ketamine metabolite hydroxynorketamine actually activates a different receptor, alpha-amino-3-hydroxy-5-methyl-4-isoxazole proprionic acid or AMPA. In addition, as isolated, the metabolite does not cause dissociative effects associated with ketamine in it’s usual form. Keep in mind that these are animal studies and much research remains to be done on the complicated mechanism of action and it’s refinement for use in humans.

Nonetheless what I feel is most important about this study is the further legitimization of Ketamine as a significant medication in the treatment of patients with refractory depression. And how knowing more about the pharmacodynamics and pharmacokinetics of Ketamine, the research community can further explore potential development of a new line of medications then hopefully work expeditiously and with a minimum of side effects.

Ketamine Wellness Centers

Ketamine Wellness Center’s mission is to provide personalized, compassionate, high-quality care for people suffering from afflictions where Ketamine infusions have proven a successful treatment option (Depression, Chronic Pain, PTSD, OCD, Suicidality) while actively researching Ketamine’s efficacy to treat additional conditions. There is hope. There is help.

PHONE:
855-KET-WELL (1-855-538-9355)

FAX:
844-KET-WELL (1-844-538-9355)

EMAIL:
info@ketaminewellnesscenters.com

CLINIC LOCATIONS:

Chicago, Illinois
603 E Diehl Rd, Suite #139 Naperville, IL 60563

Dallas-Fort Worth, Texas
6144 Precinct Line Road, Suite 100 Hurst, TX 76054

Denver, Colorado
7261 S Broadway, Suite 10-L Littleton, CO 80122

Houston, Texas
12807 Haynes Rd. Building A, Unit 1 Houston, TX 77066

Jacksonville, Florida
3753-2 Cardinal Point Drive Jacksonville, FL 32257

Las Vegas, Nevada
7375 S. Pecos Rd. Suite 102 Las Vegas, NV 89120

Minneapolis-St Paul, Minnesota
11995 County Road 11, Suite 220 Burnsville, MN 55337

Mesa-Gilbert, Arizona
2451 E. Baseline Rd, Suite 300 Gilbert, AZ 85234

Phoenix, Arizona
3724 N 3rd. St. Suite 201 Phoenix, AZ 85012

Reno, Nevada
1895 Plumas St. #6 Reno, NV 89509

Salt Lake City, Utah
6087 S. Redwood Road STE. B Taylorsville, UT

Seattle, Washington
34709 9th Ave S. Suite-B 200 Federal Way, WA 98003

Tucson, Arizona
3130 N Swan Rd. Tucson, AZ 85712